Form D · Biotechnology
Sinopsys Surgical, Inc.
Boulder, CO · CIK 0001511987
Offering snapshot reported Oct 17, 2014 · SEC filing
- Reported sold
- $8.26M Offering amount: $8.26M
- Investors reported
- 19 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Oct 3, 2014 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 17, 2014 | Initial | $8,258,015 | No comparison | 19 | SEC filing |
| Oct 29, 2013 | Initial | $600,000 | No comparison | 5 | SEC filing |
| Jul 16, 2012 | Initial | $1,200,001 | No comparison | 5 | SEC filing |
| Apr 6, 2011 | Initial | $109,998 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-226661
Source: Form D, filed Oct 17, 2014. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Jesse Aweida | Director |
| Robert Di Scipio | Director |
| Mark Lupa | Director |
| Harry Ross | Director, Executive |
| Donald Schomer | Director |
| Dan Watkins | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
1110 Linden Ave
Boulder, CO, 80304
Boulder, CO, 80304